23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Immunocore Holdings Plc › 2025-2026

Immunocore Holdings Plc 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Immunocore Holdings Plc’s Form 8-K, filed May 27, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 10Reported items
  • 153Asset managers, any item
  • 869Fund votes
  • May 27, 2026Meeting date

Results at a glance

Meeting of May 27, 2026: 9 items on Immunocore Holdings Plc’s Form 8-K, filed May 27, 2026: 9 passed (calculated).

Dissent

Notable dissent: 1 say-on-pay vote (77.5% support); 2 other board items (22.8%, 22.8% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Tang Capital (13F, 5.6%, as of September 30, 2026) · Caligan Partners (13F, 3.2%, as of September 30, 2026)

Explore Immunocore Holdings Plc in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Immunocore Holdings Plc

These tallies are Immunocore Holdings Plc’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Immunocore Holdings Plc — official shareholder meeting results, meeting held May 27, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
To re-appoint as a director of the Company William Pao, M.D., Ph.D. 38,040,755254,8528,233 ---- 99.3%Passed (calculated)—
To re-appoint as a director of the Company Kristine Peterson. 29,537,8008,744,38321,657 ---- 77%Passed (calculated)—
To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. 29,682,1698,600,02921,642 ---- 78%Passed (calculated)—
To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2026. 38,294,6669848,190 ---- 99.9%Passed (calculated)—
To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders 38,294,5239668,351 ---- 99.9%Passed (calculated)—
To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2026. 38,293,2692,4818,090 ---- 99.9%Passed (calculated)—
To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the "2025 U.K. 38,287,98794414,909 ---- 99.9%Passed (calculated)—
To approve the directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the Proxy Statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remunerat 29,504,6928,713,57385,575 ---- 77%Passed (calculated)—
To authorize the Company to make political donations/incur political expenditure. 38,213,34082,1138,387 ---- 99.8%Passed (calculated)—

Source: Immunocore Holdings Plc, Form 8-K, filed with the SEC on May 27, 2026 — read the filing on EDGAR.

How asset managers voted at the Immunocore Holdings Plc 2025-2026 meeting

153 asset managers disclosed a vote on at least one Immunocore Holdings Plc item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Immunocore Holdings Plc’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

To re-appoint as a director of the Company Kristine Peterson.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%AGAINST
FOR: 29,537,800AGAINST: 8,744,383
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association.

Immunocore Holdings Plc’s own tally for this item (“Resolution 3 : To re-appoint as a director of the Company Kristine Peterson.”): 29,537,800 for, 8,744,383 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 11,271,186 for, 748,635 against, 5,130 abstained.

FOR
FOR: 11,271,186AGAINST: 748,635ABSTAIN: 5,130
Largest asset managers voting on “To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS0407,373 00Against
Principal0239,000 00Against
BlackRock228,7210 00For
HUSSMAN INVESTMENT TRUST120,0000 00For
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.035,726 00Against
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC022,978 00Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC020,500 00Against
AIG/SunAmerica08,302 00Against
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds04,600 00Against
ALPS ETF Trust04,127 00Against

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To re-appoint as a director of the Company William Pao, M.D., Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 38,040,755AGAINST: 254,852
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of association.

Immunocore Holdings Plc’s own tally for this item (“Resolution 2 : To re-appoint as a director of the Company William Pao, M.D., Ph.D.”): 38,040,755 for, 254,852 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 12,019,821 for, 5,130 abstained.

FOR
FOR: 12,019,821ABSTAIN: 5,130
Largest asset managers voting on “To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of associatio” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
HUSSMAN INVESTMENT TRUST120,0000 00For
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 34 asset managers

The 34 asset managers below reported 11,899,821 for, 5,130 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,899,821ABSTAIN: 5,130
Largest asset managers voting on “To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For
ETFis Series Trust I3,9450 00For

Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).

To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the "2025 U.K.

Calculated outcomeCORPORATE GOVERNANCEPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,287,987AGAINST: 944
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2025.

Immunocore Holdings Plc’s own tally for this item (“Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the "2025 U.K.”): 38,287,987 for, 944 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 11,959,821 for, 5,130 abstained.

FOR
FOR: 11,959,821ABSTAIN: 5,130
Largest asset managers voting on “To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2025.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To authorize the Company to make political donations/incur political expenditure.

Calculated outcomeOTHER SOCIAL ISSUESPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 38,213,340AGAINST: 82,113
Details: official tally, votes by 35 asset managers

Immunocore Holdings Plc’s own tally for this item (“Resolution 10 : To authorize the Company to make political donations/incur political expenditure.”): 38,213,340 for, 82,113 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 12,221,721 for, 120,000 against, 5,130 abstained.

FOR
FOR: 12,221,721AGAINST: 120,000ABSTAIN: 5,130
Largest asset managers voting on “To authorize the Company to make political donations/incur political expenditure.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
HUSSMAN INVESTMENT TRUST0120,000 00Against
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy…

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%AGAINST
FOR: 29,682,169AGAINST: 8,600,029

Prior year: 85.0% for (May 15, 2025 meeting) ▼ 7.5 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.

Immunocore Holdings Plc’s own tally for this item (“Resolution 4: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.”): 29,682,169 for, 8,600,029 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 33 asset managers voting on “To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST060,000 00Against
New York Life057,881 00Against
STEWARD FUNDS, INC.035,726 00Against
Tema ETF Trust30,6510 00For
Lord Abbett028,532 00Against
Northwestern Mutual26,5530 00For
Equitable12,62713,700 00Mixed
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC022,978 00Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica08,302 00Against
Empower05,912 00Against
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds04,600 00Against
ALPS ETF Trust04,127 00Against

Fund voting reports, all 33 managers: 12,034,009 for, 247,700 against, 5,130 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 127 asset managers voting on “To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
RTW INVESTMENTS, LP4,869,7980 00For
Fidelity4,720,4240 00For
Wellington3,441,8400 00For
PRIMECAP MANAGEMENT CO/CA/3,433,5010 00For
T. Rowe Price2,265,2371,364 00For
Vestal Point Capital, LP01,972,943 00Against
Deep Track Capital, LP1,921,8730 00For
Logos Global Management LP1,450,0000 00For
BVF INC/IL1,294,4630 00For
Janus Henderson1,189,4240 00For
Kynam Capital Management, LP00 0884,937Withhold
ARMISTICE CAPITAL, LLC655,0920 00For
Two Sigma0651,888 00Against
Fiera Capital Corp0594,751 00Against
Point720407,648 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/407,3730 00For
Hudson Bay Capital Management LP0350,766 00Against
PRINCIPAL GLOBAL INVESTORS330,5180 00For
Woodline Partners LP283,5080 00For
Candriam S.C.A.0269,729 00Against
ACADIAN ASSET MANAGEMENT LLC0200,924 00Against
NEW YORK STATE COMMON RETIREMENT FUND182,7400 00For
Trails Edge Capital Partners, LP179,8970 00For
MARSHALL WACE, LLP172,6850 00For
Aberdeen0116,857 00Against

Institutional-manager reports, all 127 managers: 27,604,566 for, 5,019,288 against, 884,937 withheld, 105 abstained. Showing the 25 largest; every one is in the interactive database (link above).

To approve the directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to…

Calculated outcomeFund totals may overlapCOMPENSATIONPassed (calculated)

Combines 5 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%AGAINST
FOR: 29,504,692AGAINST: 8,713,573
Details: description as filed, official tally, votes by 38 asset managers

Description as filed by funds: To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on 26 to 56 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on A7 to A18 of Annex A).

Immunocore Holdings Plc’s own tally for this item (“Resolution 9 : To approve the directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the Proxy Statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the ”): 29,504,692 for, 8,713,573 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 33 asset managers voting on “To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Anne” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST00 60,0000Abstain
New York Life057,881 00Against
STEWARD FUNDS, INC.035,726 00Against
Tema ETF Trust30,6510 00For
Lord Abbett028,532 00Against
Northwestern Mutual26,5530 00For
Equitable12,62713,700 00Mixed
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC022,978 00Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica08,302 00Against
Empower05,912 00Against
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds04,600 00Against
ALPS ETF Trust04,127 00Against

Fund voting reports, all 33 managers: 12,034,009 for, 187,700 against, 65,130 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 5 asset managers voting on “To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Anne” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fiera Capital Corp0594,751 00Against
BlackRock54,179352 00For
Vident Advisory, LLC01,190 00Against
Argent Trust Co096 00Against
Keel Point, LLC012 00Against

Institutional-manager reports, all 5 managers: 54,179 for, 596,401 against.

To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,293,269AGAINST: 2,481
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2026.

Immunocore Holdings Plc’s own tally for this item (“Resolution 7 : To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2026.”): 38,293,269 for, 2,481 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 12,281,721 for, 5,130 abstained.

FOR
FOR: 12,281,721ABSTAIN: 5,130
Largest asset managers voting on “To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,294,523AGAINST: 966
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.

Immunocore Holdings Plc’s own tally for this item (“Resolution 6 : To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general mee”): 38,294,523 for, 966 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 12,281,721 for, 5,130 abstained.

FOR
FOR: 12,281,721ABSTAIN: 5,130
Largest asset managers voting on “To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. s” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,294,666AGAINST: 984

Prior year: 100.0% for (May 15, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2026.

Immunocore Holdings Plc’s own tally for this item (“Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending Decemb”): 38,294,666 for, 984 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 11,959,821 for, 5,130 abstained.

FOR
FOR: 11,959,821ABSTAIN: 5,130
Largest asset managers voting on “To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
AuguStar00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).

Largest Immunocore Holdings Plc shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 50,865,574 shares outstanding at the time of that meeting.

Fund voting reports: top Immunocore Holdings Plc shareholders by shares voted on “To approve, on advisory basis, the compensation of the Company's named executive officers, as…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 9.75%
2Fidelity 6.02%
3T. Rowe Price 2.80%
4PRIMECAP Odyssey Funds 2.25%
5BlackRock 1.08%
6MFS 0.80%
7Principal 0.47%
8Hartford 0.19%
9HUSSMAN INVESTMENT TRUST 0.12%
10New York Life 0.11%
Institutional-manager reports: top Immunocore Holdings Plc shareholders by shares voted on “To approve, on advisory basis, the compensation of the Company's named executive officers, as…”, 2025-2026
#Asset manager % of shares outstanding
1RTW INVESTMENTS, LP 9.57%
2Fidelity 9.28%
3Wellington 6.77%
4PRIMECAP MANAGEMENT CO/CA/ 6.75%
5T. Rowe Price 4.46%
6Vestal Point Capital, LP 3.88%
7Deep Track Capital, LP 3.78%
8Logos Global Management LP 2.85%
9BVF INC/IL 2.54%
10Janus Henderson 2.34%

Reported Immunocore Holdings Plc holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Immunocore Holdings Plc holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Bahija Jallal, Ph.D.5,137,769 10.10%Proxy statement (DEF 14A), table as of April 2, 2026
Entities affiliated with RTW4,869,798 9.57%Proxy statement (DEF 14A), table as of April 2, 2026
FMR (Fidelity)4,829,154 9.49%Form 13F, quarter ended March 31, 2026
Wellington Management4,706,168 9.25%Form 13F, quarter ended March 31, 2026
Entities affiliated with FMR LLC4,386,070 8.62%Proxy statement (DEF 14A), table as of April 2, 2026
PRIMECAP Management Company3,772,234 7.42%Proxy statement (DEF 14A), table as of April 2, 2026
Bellevue Asset Management AG2,796,803 5.50%Proxy statement (DEF 14A), table as of April 2, 2026
Entities affiliated with Tang Capital2,605,608 5.12%Proxy statement (DEF 14A), table as of April 2, 2026
Vestal Point Capital, LP1,800,000 3.54%Schedule 13G, filed August 14, 2026
Point721,102,271 2.17%Form 13F, quarter ended March 31, 2026

Percentages above are of 50,865,574 shares outstanding, as reported by Immunocore Holdings Plc on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Immunocore Holdings Plc's shareholder meeting held May 27, 2026, in the 2025-2026 proxy season, 153 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 869 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on advisory basis, the compensation of the Company's named executive officers, as… — FOR was 78% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Immunocore Holdings Plc's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 27, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Immunocore Holdings Plc’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Immunocore Holdings Plc proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Immunocore Holdings (IMCR) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/immunocore-holdings-plc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.